1, 25-dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets

  • Toshimitsu Matsui
  • , Yoshinobu Nakao
  • , Tamio Koizumi
  • , Toshitaro Nakagawa
  • , Takuo Fujita

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

The biologically active vitamin D metabolite, 1,25-(OH)2D3 suppressed phytohaemagglutinin (PHA)-induced lymphocyte proliferation dose-dependently (0.1 nM-100nM), and decreased the OKT4+/OKT8+ ratio and transferrin-receptor-positive (OKT9+) cells. A possible parallelism between expression of 1,25-(OH) 2D3 receptors and interleukin 2 (IL2)-receptors recognized by anti-Tac antibody was not confirmed in this study. However, the addition of exogenous IL2 abolished the inhibitory effects of 1,25-(OH) 2D3 on PHA-stimulated T-cell proliferation, and the decrease of OKT4+ and OKT9+ T-cell in this population. Among various vitamin D3 analogues examined, 1,25-(OH) 2D3 was the most potent antiproliferative effect, followed in order by 1,24S-(OH) 2D3, 1α OH D3, 25 OH D3 and 24, 25-(OH) 2D3.

Original languageEnglish
Pages (from-to)95-101
Number of pages7
JournalLife Sciences
Volume37
Issue number1
DOIs
StatePublished - 8 Jul 1985
Externally publishedYes

Fingerprint

Dive into the research topics of '1, 25-dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets'. Together they form a unique fingerprint.

Cite this